Wells Fargo & Company Upgrades Doximity (NYSE:DOCS) to Strong-Buy

Doximity (NYSE:DOCSGet Free Report) was upgraded by stock analysts at Wells Fargo & Company from a “hold” rating to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.

Several other research firms also recently weighed in on DOCS. Truist Financial raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 8th. Wall Street Zen downgraded Doximity from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. Barclays raised Doximity to a “strong-buy” rating in a research report on Monday, December 8th. Royal Bank Of Canada raised Doximity to a “moderate buy” rating in a research note on Thursday, January 8th. Finally, The Goldman Sachs Group raised Doximity from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Three research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy”.

Check Out Our Latest Stock Analysis on DOCS

Doximity Trading Down 0.4%

Shares of DOCS opened at $41.11 on Tuesday. Doximity has a 12 month low of $39.95 and a 12 month high of $85.21. The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 32.63, a PEG ratio of 1.91 and a beta of 1.39.

Doximity Company Profile

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

Featured Articles

Analyst Recommendations for Doximity (NYSE:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.